AU8731798A - Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors - Google Patents

Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors

Info

Publication number
AU8731798A
AU8731798A AU87317/98A AU8731798A AU8731798A AU 8731798 A AU8731798 A AU 8731798A AU 87317/98 A AU87317/98 A AU 87317/98A AU 8731798 A AU8731798 A AU 8731798A AU 8731798 A AU8731798 A AU 8731798A
Authority
AU
Australia
Prior art keywords
kynurenine
heterocyclic compounds
fused heterocyclic
hydroxylase inhibitors
hydroxylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87317/98A
Other languages
English (en)
Inventor
Felicita Greco
Franco Heidempergher
Paolo Pevarello
Carmela Speciale
Mario Varasi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Publication of AU8731798A publication Critical patent/AU8731798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU87317/98A 1997-07-30 1998-07-02 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors Abandoned AU8731798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9716101 1997-07-30
GBGB9716101.2A GB9716101D0 (en) 1997-07-30 1997-07-30 Fused heterocyclic compounds
PCT/EP1998/004218 WO1999006375A1 (fr) 1997-07-30 1998-07-02 Composes heterocycliques fondus et utilisation de ces composes comme inhibiteurs de la kynurenine-3-hydroxylase

Publications (1)

Publication Number Publication Date
AU8731798A true AU8731798A (en) 1999-02-22

Family

ID=10816708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87317/98A Abandoned AU8731798A (en) 1997-07-30 1998-07-02 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors

Country Status (6)

Country Link
EP (1) EP1001941A1 (fr)
JP (1) JP2001512107A (fr)
AU (1) AU8731798A (fr)
CA (1) CA2296606A1 (fr)
GB (1) GB9716101D0 (fr)
WO (1) WO1999006375A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080058515A1 (en) * 2003-07-29 2008-03-06 David Harold Drewry Chemical Compounds
US10065972B2 (en) * 2014-04-23 2018-09-04 Mitsubishi Tanabe Pharma Corporation Bicyclic or tricyclic heterocyclic compound
WO2023077046A1 (fr) 2021-10-29 2023-05-04 Arcus Biosciences, Inc. Inhibiteurs d'hif-2alpha et leurs procédés d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
GB9522617D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity

Also Published As

Publication number Publication date
WO1999006375A1 (fr) 1999-02-11
GB9716101D0 (en) 1997-10-01
CA2296606A1 (fr) 1999-02-11
EP1001941A1 (fr) 2000-05-24
JP2001512107A (ja) 2001-08-21

Similar Documents

Publication Publication Date Title
AU2980797A (en) Fused heterocyclic compounds and medicinal uses thereof
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
AU1608397A (en) Heterocyclic compounds useful as pharmaceutical agents
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
EG24041A (en) New heterocyclic compounds
AU1978699A (en) Heterocyclic compounds
AU7648698A (en) Heterocyclic derivatives and their use as antithrombotic agents
GB9715892D0 (en) Heterocyclic compounds
AU4009795A (en) Heterocyclic compounds and their use
AUPP003197A0 (en) New heterocyclic compounds
AU9317298A (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
AU7550398A (en) Heterocyclic compounds, their production and use
AU7907498A (en) Novel heterocyclic compounds
AU7907298A (en) Novel heterocyclic compounds
AU3440597A (en) N-phenylimino heterocyclic derivatives and their use as herbicides
AU9068598A (en) Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
AU6291098A (en) Novel heterocyclic compounds
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
ZA9811346B (en) Substituted heterocyclic benzocycloalkenes and their use as an analgesic
AU1081897A (en) Heterocyclic compounds and their use
AU4712696A (en) The use of heterocyclic compounds
AU5999698A (en) Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
AUPO622597A0 (en) New heterocyclic compounds
AU8179198A (en) Nucleobase heterocyclic combinatorialization

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase